BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 23951641)

  • 1. [Who must have tuberculosis screening? Characteristics of risk patients].
    MMW Fortschr Med; 2013 May; 155(9):16-8. PubMed ID: 23951641
    [No Abstract]   [Full Text] [Related]  

  • 2. Predicting progression to active tuberculosis: A rate-limiting step on the path to elimination.
    Lalvani A; Berrocal-Almanza LC; Halliday A
    PLoS Med; 2019 May; 16(5):e1002814. PubMed ID: 31125334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Tuberculosis and nontuberculous mycobacterial infections].
    Wagner D; Kern WV
    Dtsch Med Wochenschr; 2011 Apr; 136(14):691-4. PubMed ID: 21448828
    [No Abstract]   [Full Text] [Related]  

  • 4. Private firms form initiative to offer accurate and affordable TB tests.
    Kay M
    BMJ; 2013 Apr; 346():f2161. PubMed ID: 23564925
    [No Abstract]   [Full Text] [Related]  

  • 5. [Neonatal exposure to active pulmonary tuberculosis in a maternity ward: screening and clinical course of a cohort of exposed infants].
    Perry A; Angoulvant F; Chadelat K; De Lauzanne A; Houdouin V; Kheniche A; Lorrot M; Mesples B; Nouyrigat V; Aujard Y; Gaudelus J; Grimprel E; Faye A
    Arch Pediatr; 2012 Apr; 19(4):396-403. PubMed ID: 22377245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening and follow-up of children exposed to tuberculosis cases, Luanda, Angola.
    Fortunato I; Sant'Anna C
    Int J Tuberc Lung Dis; 2011 Oct; 15(10):1359-61. PubMed ID: 22283895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Current tuberculin test].
    Spiess H
    Munch Med Wochenschr; 1970 Jan; 112(1):1-5. PubMed ID: 5538068
    [No Abstract]   [Full Text] [Related]  

  • 8. [Tuberculosis control].
    Schoch O
    Ther Umsch; 2011 Jul; 68(7):381-7. PubMed ID: 21728156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness analysis of interferon-γ release assays versus chest X-ray for annual tuberculosis screening of healthcare workers.
    Kowada A; Deshpande GA; Takahashi O; Shimbo T; Fukui T
    J Hosp Infect; 2011 Jun; 78(2):152-4. PubMed ID: 21440954
    [No Abstract]   [Full Text] [Related]  

  • 10. Diagnosis and treatment of latent infection with Mycobacterium tuberculosis.
    Chee CB; Sester M; Zhang W; Lange C
    Respirology; 2013 Feb; 18(2):205-16. PubMed ID: 23107218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tuberculosis surveillance in a therapeutic community.
    Foley ME; Ehr AP; Raza B; Devlin CJ
    J Addict Dis; 1995; 14(1):55-65. PubMed ID: 7632747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for latent tuberculosis infection: performance of tuberculin skin test and interferon-γ release assays under real-life conditions.
    Kleinert S; Tony HP; Krueger K; Detert J; Mielke F; Rockwitz K; Schwenke R; Burmester GR; Diel R; Feuchtenberger M; Kneitz C
    Ann Rheum Dis; 2012 Nov; 71(11):1791-5. PubMed ID: 22586160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is Universal Screening Necessary? Incidence of Tuberculosis among Tibetan Refugees Arriving in Calgary, Alberta.
    Lim R; Jarand J; Field SK; Fisher D
    Can Respir J; 2016; 2016():8249843. PubMed ID: 28127230
    [No Abstract]   [Full Text] [Related]  

  • 14. Tuberculosis screening in patients with psoriasis before antitumour necrosis factor therapy: comparison of an interferon-gamma release assay vs. tuberculin skin test.
    Laffitte E; Janssens JP; Roux-Lombard P; Thielen AM; Barde C; Marazza G; Panizzon RG; Saurat JH
    Br J Dermatol; 2009 Oct; 161(4):797-800. PubMed ID: 19659473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tuberculosis screening in a dialysis unit: detecting latent tuberculosis infection is only half the problem.
    Brij SO; Beck SC; Kleemann F; Jack AL; Wilkinson C; Enoch DA
    J Hosp Infect; 2014 Aug; 87(4):241-4. PubMed ID: 25027226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prevalence of latent infection with Mycobacterium tuberculosis in Mazovia Region using interferon gamma release assay after stimulation with specific antigens ESAT-6 and CFP-10].
    Kuś J; Demkow U; Lewandowska K; Korzeniewska-Koseła M; Rabczenko D; Siemion-Szcześniak I; Białas-Chromiec B; Bychawska M; Sapigórski P; Maciejewski J
    Pneumonol Alergol Pol; 2011; 79(6):407-18. PubMed ID: 22028119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An evaluation of the use of a negative interferon-γ release assay for tuberculosis screening before TNF antagonist therapy.
    Woodfield G; Passey-Heaton B; Chakrabarti A; Pozniak A; Loebinger MR
    Eur Respir J; 2014 Nov; 44(5):1369-72. PubMed ID: 25186258
    [No Abstract]   [Full Text] [Related]  

  • 18. The frequency of tuberculosis chemoprophylaxis prior to TNF-α inhibitor treatment, and the incidence tuberculosis infection using a two-step screening algorithm for latent tuberculosis infection: data from the BioRx.si registry.
    Tomsic M; Rotar Z
    Ann Rheum Dis; 2012 Nov; 71(11):1909-11. PubMed ID: 22805974
    [No Abstract]   [Full Text] [Related]  

  • 19. Diagnosis of latent tuberculosis infection (LTBI) before anti-TNF-alpha treatment--the tuberculin skin test is useful.
    Goujon C; Nosbaum A; Bensaid B; Rozières A; Nicolas JF; Bérard F
    Eur J Dermatol; 2012; 22(5):701-2. PubMed ID: 23032063
    [No Abstract]   [Full Text] [Related]  

  • 20. [Primary infection and pulmonary tuberculosis].
    Toujani S; Ben Salah N; Cherif J; Mjid M; Ouahchy Y; Zakhama H; Daghfous J; Beji M; Mehiri-Ben Rhouma N; Louzir B
    Rev Pneumol Clin; 2015; 71(2-3):73-82. PubMed ID: 25749628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.